Skip to main content

Digital Health (DH)

The Neural Analytics Lucid™ M1 transcranial Doppler Ultrasound System is indicated as an adjunct to the standard clinical practices for measuring and displaying cerebral blood flow velocity within the major conducting arteries and veins of the head and neck. Additionally, the Lucid™ M1 System measures the occurrence of transient emboli signals within the blood stream.

Technology topic

Digital Health (DH)

The Digital Health topic aims to support the early-stage development of novel devices, components, systems, algorithms, networks, applications or services that will enable the transformation of healthcare from reactive, hospital-centered and indemnity-based to proactive, person-centered, preventive and cost-efficient.

Subtopics are not aimed at supporting clinical trials, the clinical validation of information technologies, or medical devices or studies performed primarily for regulatory purposes. Limited studies with human subjects may be acceptable to the extent that they are performed in support of feasibility, such as proof-of-concept studies of early-stage technologies. Proposals that request support for clinical studies will be deemed noncompliant with the SBIR/STTR solicitations and returned without review.


DH1. Assistive, Enabling and Rehabilitative technologies
DH2. Health and Biomedical informatics
DH3. Health in Underserved Communities
DH4. Healthcare Workflow, Economics and Delivery
DH5. Medical Diagnostics and Devices
DH6. Physical, Mental and Behavioral Health
DH7. Other Digital Health Technologies

Program director

Alastair Monk headshot

Alastair Monk